Related Experiment Video
Updated: Dec 25, 2025
Enhancing the Engraftment of Human Induced Pluripotent Stem Cell-derived Cardiomyocytes via a Transient Inhibition of Rho Kinase Activity
Published on: July 10, 2019
Enhancing induced pluripotent stem cell toward differentiation into functional cardiomyocytes
Chian-Shiu Chien1,2,3, Chien-Ying Wang2,4, Hsin-Bang Leu1,5
1Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Insights
MicroRNA-181a enhances cardiomyocyte function by increasing HCN4 expression, offering new hope for heart repair using induced pluripotent stem cells. This discovery is crucial for advancing regenerative medicine in treating heart diseases.
Area of Science:
- Cardiovascular Research
- Stem Cell Biology
- Regenerative Medicine
Background:
- Heart diseases, particularly myocardial ischemia, are a leading global cause of death, often leading to irreversible heart damage.
- Induced pluripotent stem cell (iPSC)-derived cardiomyocytes offer potential for cardiac repair, but their functional capacity requires further investigation.
- Understanding the molecular drivers of cardiomyocyte differentiation is crucial for effective regenerative therapies.
Purpose of the Study:
- To investigate the role of microRNA-181a (miR-181a) in the differentiation and functional maturation of iPSC-derived cardiomyocytes.
- To establish a rapid differentiation platform for in vitro cardiomyogenesis.
- To assess the impact of miR-181a on cardiomyocyte beating function and underlying molecular mechanisms.
Main Methods:
- Development of a rapid in vitro differentiation platform for iPSCs into cardiomyocytes.
- Functional analysis of miR-181a-transfected iPSC-derived cardiomyocytes using time-lapse microscopy.
- Assessment of beating area and frequency in response to miR-181a modulation and HCN4 knockdown.
Main Results:
- miR-181a significantly enhanced the beating area of iPSC-derived cardiomyocytes.
- miR-181a maintained the beating frequency of iPSC-derived cardiomyocytes.
- These functional improvements were attributed to enhanced HCN4 expression mediated by miR-181a.
Conclusions:
- miR-181a plays a critical role in maintaining the proper beating function of iPSC-derived cardiomyocytes.
- Targeting miR-181a presents a promising therapeutic strategy for enhancing the efficacy of stem cell-based cardiac repair.
- Further research into microRNA regulation can advance regenerative medicine for heart failure.
Background:
Heart diseases, especially myocardial ischemia, remain one of the leading causes of mortality worldwide and usually result in irreparable cardiomyocyte damage and severe heart failure. Recent advances in induced pluripotent stem cell (iPSC) technologies for applied regenerative medicine and stem cell research, especially for iPSC-derived cardiomyocytes have increased the hope for heart repair. However, the driver molecules of myocardial differentiation and the functional reconstruction capacity of iPSC-derived cardiomyocytes are still questionable.
Methods:
Herein, we established a rapid differentiated platform that is involved in cardiomyogenic differentiation and maturation from iPSCs in vitro. Functional analysis is performed in miR-181a-transfected iPSC-derived cardiomyocyte (iPSC-cardio/miR-181a) under a time-lapse microscope. In addition, we calculated the beating area and frequency of iPSC-cardio/miR-181a cells in the presence of HCN4 shRNA or miR-181a SPONGE.
Results:
miR-181a enhanced the beating area and maintained the beating frequency of iPSC-derived cardiomyocytes by enhancing HCN4 expression.
Conclusion:
miR-181a would play a key role on maintaining proper beating function in iPSC-derived cardiomyocytes.
